AASLD guidelines for treatment of chronic hepatitis B. HEPATOLOGY 2016;63:261-283. http://onlinelibrary.wiley.com/doi/10.1002/hep.28156/ full.Terrault NA, Bzowej NH, chang KM, et a1. AASLD guidelines for treatment of Chronic hepatitis B[J]. Hepatology,2016,63(1):261-283....
Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2.Lok, A. S., and B. J. McMahon. 2009. Chronic hepatitis B: update 2009. Hepatology 50 (3):661-662.Lok ASF, McMahon BJ. Chronic hep- atitis B: update 2009. Hepatology 2009; 50(3): 661-662....
接种乙肝病毒(HBV)疫苗时,三剂乙肝疫苗(HEPB3)与儿童期其他常规疫苗一起接种(通常制成五联疫苗)。HCV表示丙肝病毒。 † 《2017年全球肝炎报告》5和《全球卫生部门战略,2016—2021年》4设立的具体目标是95%。 ‡ 《全球卫生部门战略,2016—2021年》4将注射安全表述为在医疗机构内外,安全注射(使用有安全设计的...
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67(4):1560-1599 View Article 7 Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, et al. Prevention of hepatitis B virus infection in the United States...
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99. Article PubMed Google Scholar Sarin SK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hep Intl. ...
AASLD Practice Guideline: Management of Hepatocellular Carcinoma: An update In the previous guideline, groups were specified for which surveillance was likely to be cost-effective because the hepatocellular carcinoma (HCC) incidence was high enough. New data on defining HCC risk have emerged for ...
Entry inhibition is efficiently achieved using Myrcludex B (Bulevirtide/Hepcludex), a small myristoy lated lipopeptide containing the same aminoacid sequence of the preS1 domain of the HBV envelope protein and a first-in-class entry inhibitor blocking the NTCP cellular receptor.97 Both ...
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99. https://doi.org/10.1002/hep.29800. Article PubMed Google Scholar American Gastroenterological Association. AGA Institute Guidelines on Hepatitis B Reactivation ...
Talwalkar (Chair, AASLD), Hari S. Conjeevaram, Michael Porayko, Raphael B. Merriman, Peter L. M. Jansen, and Fabien Zoulim. This guideline has been approved by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver and represents ...
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study Gut, 60 (2011), pp. 1109-1116 Cross...